🔎 Trials Near Me

መነሻ › ዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ › Ohio › Cincinnati

በCincinnati፣ OH ለዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ የሚደረጉ 11 ጥናቶች በCincinnati እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Oncology Hematology Care - Kenwood, Cincinnati
  • University of Cincinnati Medical Center, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06500273

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Cincinnati Children's Hospital Medical Center, Cincinnati
እድሜ ከ0 እስከ 38 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06131801

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • University of Cincinnati Cancer Center-West Chester, West Chester · 15 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06649812

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Oncology_Hematology Care Clinical Trials, LLC (OHC) ( Site 8002), Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06717347

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Saint Elizabeth Medical Center Edgewood ( Site 0165), Edgewood · 8 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05139017

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Cincinnati Medical Center ( Site 0156), Cincinnati
  • Saint Elizabeth Medical Center Edgewood ( Site 0141), Edgewood · 8 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06890884

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Cincinnati (UC) Physicians Company, LLC, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Oncology Hematology Care Clinical Trials, Cincinnati
  • University of Cincinnati, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT07188558

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Cincinnati Medical Center, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁላይ 2026 · NCT05131022

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Cincinnati, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT04775745

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Cincinnati, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2022 · NCT04502394

በሌሎች ከተሞች ለዲፊዩዝ ላርጅ ቢ-ሴል ሊምፎማ የሚደረጉ ጥናቶች

በCincinnati ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።